Figure 6.
Pituitary T1-weighted postgadolinium coronal MRIs before (a) and after (b) 3 cycles of cisplatin and etoposide demonstrating significant tumor shrinkage of residual left cavernous sinus and Meckel's cave carcinoma.
Pituitary T1-weighted postgadolinium coronal MRIs before (a) and after (b) 3 cycles of cisplatin and etoposide demonstrating significant tumor shrinkage of residual left cavernous sinus and Meckel's cave carcinoma.